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Abstract
Cell migration is of paramount importance to organism development and maintenance as well as multiple pathological
processes, including cancer metastasis. The RhoGTPases Rac1 and RhoA are indispensable for cell migration as they regulate
cell protrusion, cell-extracellular matrix (ECM) interactions and force transduction. However, the consequences of their
activity at a molecular level within the cell remain undetermined. Using a combination of FRET, FRAP and biochemical
analyses we show that the interactions between the focal adhesion proteins vinculin and paxillin, as well as the closely
related family member Hic-5 are spatially and reciprocally regulated by the activity of Rac1 and RhoA. Vinculin in its active
conformation interacts with either paxillin or Hic-5 in adhesions in response to Rac1 and RhoA activation respectively, while
inactive vinculin interacts with paxillin in the membrane following Rac1 inhibition. Additionally, Rac1 specifically regulates
the dynamics of paxillin as well as its binding partner and F-actin interacting protein actopaxin (a-parvin) in adhesions.
Furthermore, FRET analysis of protein:protein interactions within cell adhesions formed in 3D matrices revealed that, in
contrast to 2D systems vinculin interacts preferentially with Hic-5. This study provides new insight into the complexity of
cell-ECM adhesions in both 2D and 3D matrices by providing the first description of RhoGTPase-coordinated protein:protein
interactions in a cellular microenvironment. These data identify discrete roles for paxillin and Hic-5 in Rac1 and RhoA-
dependent cell adhesion formation and maturation; processes essential for productive cell migration.
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Introduction
Cell migration is critical for normal development and wound
repair, as well as pathophysiologic events such as cancer
metastasis. The integrin family of heterodimeric transmembrane
proteins are essential for cell migration as they serve as both the
physical link between the cell and its microenvironment as well as
a conduit for the transmission of force and bidirectional signals
necessary for coordination of the cell motility machinery [1].
Integrins cluster in the membrane following their activation by
either intracellular or external cues and recruit a functionally
diverse array of intracellular proteins to form characteristic
adhesion contacts [2]. The formation and stabilization of
integrin-mediated adhesions is dependent on the activity of the
RhoGTPase family of proteins, in particular Rac1 and RhoA. The
activation of Rac1 at the cell periphery stimulates adhesion
formation as well as actin-mediated cell protrusion, while RhoA
activation promotes adhesion contact maturation and growth as
well as cell contractility [3].
Proteins that localize to adhesion contacts can be subdivided
into functional groups including but not limited to structural,
adaptor and signaling proteins [4]. Paxillin and its closely related
family member Hic-5 (ARA55, TGFB1l1) are two such adaptor
proteins, which function as molecular scaffolds to spatiotemporally
integrate the function and enzymatic activity of a variety of
proteins at integrin adhesion sites [5], [6]. In contrast, vinculin
performs a structural role and is necessary for adhesion
strengthening and force transmission through its interaction with
talin and the actin cytoskeleton [7], [8], [9], [10].
Paxillin binds directly to vinculin [11] and both proteins are
amongst the first recognized members of the integrin adhesome
[4], [12], [13]. More recently, Hic-5 was also found to interact
with vinculin in vitro [14]. Whether the paxillin and Hic-5
interactions with vinculin are functionally and spatially distinct
in a cellular environment remains to be determined.
Integrin-extracellular matrix (ECM) adhesion contacts formed
on 2D substrates can be classified by their size and location in the
cell. Focal complexes are small (,1 mm
2) Rac1-mediated adhesion
contacts that form at the cell periphery, particularly at areas of
membrane/lamellipodial protrusion [15], [16], [17], [18]. Focal
complexes either disassemble rapidly or transition to the larger
(.1 mm
2) spatiotemporally distinct RhoA- and force-dependent,
focal adhesions [19], [20], [21]. Importantly, despite the well-
characterized roles and absolute requirement for the RhoGTPases
in integrin-mediated adhesion to the ECM [17], [19], [20], [21],
[22], [23], the consequences of their activation at a molecular
interaction level in a cellular environment and thus how they are
able to regulate cell migration is relatively unexplored.
Paxillin has been shown to modulate cell migration through
coordinating 2D adhesion disassembly [24] as well as through
regulating the activity of the RhoGTPases [5]. Hic-5 has also
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migration [25], [26] and may also serve a mechanosensory role
[27]. Vinculin, in addition to controlling adhesion strengthening,
also modulates adhesion turnover [28] to regulate cell migration.
More recently paxillin, Hic-5 and vinculin have all been identified
as components of adhesion contacts formed during migration
through in vivo-relevant 3D ECM environments [25], [29].
Strikingly, in contrast to 2D systems, Hic-5 is required for 3D
adhesion formation in MDA-MB-231 breast cancer cells, while
paxillin regulates 3D adhesion assembly, stabilization and
disassembly to control mesenchymal cell invasion and plasticity
[25].
To characterize the molecular interactions occurring in
adhesion contacts through modulation of discrete RhoGTPase
signaling we have used a combination of acceptor photobleaching
Fluorescence Resonance Energy Transfer (apFRET), Fluorescence
Recovery After Photobleaching (FRAP) as well as fluorescence
colocalization and biochemical analyses. Importantly, we provide
the first description of RhoGTPase-regulated protein:protein
interactions in a cellular context in both 2D and 3D microenvi-
ronments. Herein we show that the interaction between paxillin
and vinculin in and around adhesions is spatially regulated and is
dependent on the activity of Rac1 as well as the activation status of
vinculin. In contrast, RhoA activation promotes the interaction of
Hic-5 with ‘active’ vinculin in adhesions. We also show that in
contrast to 2D adhesions the interaction between Hic-5 and
vinculin predominates in 3D adhesions. Additionally, we describe
a novel role for Rac1 in regulating paxillin dynamics in adhesions,
potentially through promoting an interaction between paxillin and
the F-actin binding protein actopaxin (a-parvin) [30].
Results and Discussion
Paxillin and Hic-5 colocalize and interact with vinculin in
adhesion contacts
Immunofluorescence imaging of endogenous paxillin and Hic-5,
using family member-specific antibodies [25], [26], as well as
vinculin in NIH 3T3 fibroblast cells revealed their localization to
cell-ECM adhesions of varying size, from small peripheral focal
complexes (,1 mm
2) to larger more mature focal adhesions
(.1 mm
2), as well as larger structures that likely represent merged
or spatially inseparable adhesions (.10 mm
2) (Figure 1A). This
subcellular distribution of paxillin and vinculin is consistent with
previous studies indicating that these proteins are two of the
earliest proteins recruited to assembling integrin-mediated adhe-
sions [18], [31], [32]. A similar analysis of the distribution of
fluorophore-tagged proteins, which have been previously shown to
function as their wild type counterparts [25], [26], [33], [34], [35],
[36], [37] also revealed colocalization between both paxillin and
vinculin (Figure 1B) and Hic-5 and vinculin (Figure 1C) in
adhesions of all sizes, which was confirmed by Pearson’s
Correlation coefficient analysis (Figure 1E). Comparable coloca-
lization in all adhesions was also observed between paxillin and
zyxin (Figure 1D and E), which are not thought to interact
directly.
Importantly, biochemical evidence of a global interaction
between vinculin and either paxillin or Hic-5 is well established
[11], [14], [38], [39]. However, their spatiotemporal association in
cells has not been determined. To investigate the subcellular
interaction of vinculin with paxillin and Hic-5 we employed
apFRET [40], [41], [42]. This technique can be used to measure
the proximity of two fluorophore-tagged proteins and thus assess
protein:protein interactions with high sensitivity on the nanometer
scale [43], [44].
NIH 3T3 cells expressing vinculin-YFP (donor) and mRFP-
paxillin (acceptor) to endogenous levels (Figure S1A) were imaged
and the FRET efficiency determined. Images were acquired in the
YFP and mRFP channel before and after .95% mRFP
photobleaching (Figure 2A) as determined by relative mRFP
mean fluorescence intensity before and after photobleaching in
cells spread and forming robust adhesions on a 2D fibronectin
substrate (Figure 2B). To control for pixel shift aberrations and
edge artifacts due to fluctuations in temperature and focus drift
during mRFP ablation, the YFP images take before and after
mRFP photobleaching were merged and pixel alignment fidelity
assessed and corrected. Only images in which all pixels could be
aligned as determined by Pearson’s Correlation and line profile
analyses were used for subsequent FRET calculations (Figur-
e S2B). Positive FRET results in an increase in donor emission
(unquenching) after mRFP photobleaching as indicated by an
increase in the fluorescence intensity of vinculin-YFP after mRFP
destruction (green line) relative to before (red line) (Figure S1B).
FRET and thus a direct interaction [45] between paxillin and
vinculin was observed in all adhesion contacts (Figure 2C). To
determine FRET efficiency strictly within an adhesion, masks were
created of cell adhesion contacts from background subtracted
vinculin-YFP images before photobleaching and FRET measure-
ments restricted to those areas. Importantly, the FRET observed
was not due to pixel shift aberrations or edge artifacts as indicated
by image alignments (Figure S1B). Similarly, in cells expressing
vinculin-YFP and mRFP-Hic-5 (Figure 2D and E) to endogenous
levels (Figure S2A) a direct interaction between the two proteins
was also observed (Figure 2E and Figure S2B). Only low
background levels of FRET (approximately 6%; Figure 2F) were
observed in control cells expressing vinculin-YFP and mRFP
vector (Figure S2C). Importantly, despite the high degree of
colocalization between paxillin and zyxin the level of FRET
(Figure S2D) was similar to that observed with vinculin-YFP and
mRFP (Figure 2F), suggesting that these two proteins do not
interact in adhesion contacts. These data indicate that in a cellular
environment, vinculin colocalizes and directly interacts with both
paxillin and Hic-5 in adhesion contacts.
Paxillin exhibits an increased interaction with vinculin in
small (,1 mm2) adhesions
The formation and maturation state of adhesion contacts have
been shown to be dependent on the activity of different signaling
proteins, for example the RhoGTPases [17], [20]. Furthermore,
the various types of integrin-mediated adhesion have been
reported to have distinct molecular compositions [46], [47],
Figure 1. Endogenous and exogenous paxillin, Hic-5 and vinculin colocalize in integrin-mediated adhesions of varying size. (A)
Immunofluorescence images of NIH 3T3 cells spread on 2D fibronectin for 4hrs and stained for paxillin (top panels), Hic-5 (middle panels) and vinculin
(bottom panels). Masks indicate that the endogenous proteins localize to all adhesions (,1 mm
2 to .10 mm
2). Blue line indicates the cell edge as
determined by F-actin staining. Representative images of cells co-expressing (B) mRFP-paxillin and (C) mRFP-Hic-5 with vinculin-YFP. Line profiles
indicate fluorophore-tagged protein colocalization in all adhesion structures. (D) Representative image and line profiles of mRFP-paxillin and zyxin-
YFP colocalization in adhesions. (E) Average Pearson’s Correlation analyses indicate a high level of colocalization of exogenous proteins. Error bars are
standard errors of the mean.
doi:10.1371/journal.pone.0037990.g001
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adhesion contact influences the interaction between either paxillin
or Hic-5 and vinculin, the FRET efficiency of the respective
protein pairs was quantified in adhesions with areas of ,1 mm
2 or
.1 mm
2. Interestingly, there was a highly significant increase in
the interaction between paxillin and vinculin in the peripheral
small adhesions (focal complexes) relative to the larger adhesions
(focal adhesions) (Figure 2F and G). In contrast, no significant
difference was observed in the FRET efficiency between Hic-5 and
vinculin in adhesions regardless of their size (Figure 2F). These
data suggest that the interaction between paxillin and vinculin is
spatially regulated and is influenced by, or may even dictate the
maturation state of the adhesion contact.
The activity of the RhoGTPases, Rac1 and RhoA, regulates
the spatial localization of the paxillin-vinculin interaction
The assembly of nascent focal complexes and their maturation
into focal adhesions is regulated by the activity of Rac1 and RhoA
respectively [17], [20]. Furthermore, active Rac1 has been shown
to colocalize predominantly with focal complexes at the leading
edge of cell protrusions [49], [50], [51]. Therefore, we hypoth-
esized that since paxillin and vinculin exhibit elevated FRET
efficiency in focal complexes their interaction may be promoted by
the activation of Rac1. To address this possibility, NIH 3T3 cells
transfected with mRFP-paxillin and vinculin-YFP were cotrans-
fected with wild type or mutant forms of myc-tagged Rac1
(Figure 3A). Cells expressing dominant negative (N17) Rac1
exhibited a significant decrease in the interaction between paxillin
and vinculin in adhesions as indicated by decreased FRET
efficiency, while expression of the dominant active (V12) Rac1
resulted in robust paxillin and vinculin interaction in small
adhesions throughout the cell (Figure 3B and C). Additionally,
N17Rac1 cells displayed a significant increase in average adhesion
area (Figure 3D) indicative of a shift towards more RhoA-
mediated mature focal adhesions and consistent with previous
reports indicating that the activities of Rac1 and RhoA may
exhibit a reciprocal relationship [52]. Indeed, analysis of myosin 2
activation, a downstream effector of RhoA, indicated an increase
in myosin light chain 2 (MLC2) phosphorylation upon expression
of N17Rac1, which is indicative of a shift towards RhoA-mediated
adhesion signaling (Figure S3A and B).
To formally test whether RhoA activation may promote the loss
of paxillin-vinculin interaction, cells were transfected with the
active form of RhoA (V14) (Figure 3A). This also resulted in a
significant loss of FRET between paxillin and vinculin in adhesion
contacts (Figure 3B and C) and an increase in average adhesion
area (Figure 3D) along with an increase in MLC2 phosphorylation
(Figure S3A and B). Importantly, the loss of interaction was not
due to a decrease in paxillin or vinculin colocalization in adhesions
as no change in the Pearson’s Correlation coefficient was observed
(Figure S4A). The role of Rac1 in regulating the interaction
between paxillin and vinculin was further evaluated using the
Rac1 inhibitor (NSC23766). Treatment with the Rac1 inhibitor
resulted in a significant loss of paxillin and vinculin interaction in
adhesions (Figure 3E), increased MLC2 activity (Figure S3C and
D) as well as an increase in adhesion area (Figure 3F) without a
decrease in their colocalization (Figure S4B). Interestingly, in
conjunction with the significant decrease in paxillin and vinculin
interaction in adhesions following RhoA activation or Rac1
inhibition, there was a striking and significant concomitant
increase in relative FRET efficiency between paxillin and vinculin
in the plasma membrane and/or cytosol relative to the FRET
efficiency observed in adhesion contacts (Figure 3B, G and
Figure S5).
Vinculin is known to associate with the plasma membrane
through its direct interaction with phosphatidylinositol-4,5-bispho-
sphate (PIP2) [53]. Indeed, along with F-actin and talin binding
this interaction is necessary for complete vinculin activation and
function [7], [54]. We used cell fractionation to examine whether
the FRET observed outside the adhesion contacts was due to
increased vinculin recruitment to the cytosol or membrane
compartments. No significant difference in either paxillin or
vinculin protein levels in the transaldolase-enriched cytosolic
fraction could be detected (Figure 3H). In contrast, a significant
2.7 fold (60.6; p,0.05) increase in endogenous vinculin but no
increase in paxillin was observed in the membrane fraction, which
was enriched in both calnexin and b1 integrin (Figure 3H).
Taken together, these data suggest that Rac1 inhibition and/or
RhoA activation may promote the redistribution of vinculin to the
plasma membrane and that this pool also directly interacts with
paxillin. This observation may also explain why we failed to
observe a significant change in the amount of co-precipitating
paxillin and vinculin (Figure 3I; p=0.44, n=3 individual
experiments) despite the loss of FRET between paxillin and
vinculin in adhesions. These data are also consistent with the role
of RhoA in the activation of PIP 5-kinase, which is essential in the
generation of PIP2 [55], [56], and may in turn lead to an increase
in vinculin membrane recruitment [57].
Rac1 inhibition and RhoA activation promotes Hic-5 and
vinculin FRET in adhesions and promotes Hic-5
translocation to stress fibers
Hic-5 has been shown to modulate the activity of RhoGTPases
in multiple cell types, for example during cancer cell 3D invasion
[25] and epithelial to mesenchymal transition (EMT) [26].
Whether Hic-5 activity/function is responsive to RhoGTPase
activity is unknown. Interestingly, when we analyzed the impact of
manipulating RhoGTPase activity on the Hic-5-vinculin interac-
tion we found that in stark contrast to paxillin (Figure 3),
expression of N17Rac1 or dominant active V14RhoA (Figure 4A)
resulted in a highly significant increase in Hic-5 and vinculin
interaction in adhesion contacts (Figure 4B and C), along with
Figure 2. Paxillin and Hic-5 are within FRET proximity of vinculin in adhesions. (A) Raw images of NIH 3T3 cells expressing the donor
(vinculin-YFP) and acceptor (mRFP-paxillin) pair used for FRET calculations before and after acceptor photobleaching. The lower panel images
highlight the complete photobleaching of the acceptor protein. (B) Mask image of the vinculin-YFP image indicating the variation of adhesion
contact area. (C) FRET efficiency image of mRFP-paxillin and vinculin-YFP with zoomed images, indicating FRET in both small and large adhesions. (D)
Raw images of NIH 3T3 cells expressing the donor (vinculin-YFP) and acceptor (mRFP-Hic-5) pair used for FRET calculations. (E) FRET efficiency image
of mRFP-Hic-5 and vinculin-YFP with zoomed images indicating FRET in both small and large adhesions. (F) Quantitation of average percentage FRET
efficiency of indicated FRET pairs in adhesions with small, focal complex-like areas (,1 mm
2) and larger more mature adhesions (.1 mm
2). Error bars
are standard errors of the mean and are compiled from analysis of all adhesions from a minimum of 9 cells from 3 individual experiments
(measurements were made from 450 to 2500 individual adhesions). Statistical analyses are relative to the mRFP and vinculin-YFP FRET control unless
otherwise indicated, * =p,0.05 and ***=p,0.0005. (G) Representative image of a vinculin-YFP-expressing NIH 3T3 cell with adhesions of (a)
,1 mm
2 and (b) 1 to 10 mm
2 indicating an increase in measured FRET efficiency between mRFP-paxillin and vinculin-YFP in the smaller focal complex-
like adhesions. Dashed blue line indicates the cell edge.
doi:10.1371/journal.pone.0037990.g002
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colocalization (Figure S4C). In contrast, expression of dominant
active V12Rac1 (Figure 4A) resulted in background levels of
FRET between mRFP-Hic-5 and vinculin-YFP (Figure 4B and C)
with a significant decrease in average adhesion area observed
(Figure 4D). Pharmacologic inhibition of Rac1 produced similar
effects to the N17Rac1 and V14RhoA-expressing cells resulting in
an increase in Hic-5 and vinculin interaction in adhesions
(Figure 4E, F and Figure S4D). Interestingly, unlike paxillin no
significant FRET was observed in the membrane between Hic-5
and vinculin (Figure 4B) regardless of GTPase activity. Further-
more, biochemical analysis of Hic-5 and vinculin interaction
revealed a small global increase (14.9% increase +/26.0, p,0.05,
n=4) in coimmunoprecipitating endogenous and fluorophore-
tagged Hic-5 with vinculin-YFP upon Rac1 inhibition (Figure 4G).
These results suggest that paxillin and Hic-5, although structurally
related, may have discrete rather than redundant roles at a
protein:protein interaction as well as a functional level [25], [58],
[59].
The functional diversity of paxillin and Hic-5 is further
highlighted by their distinct cellular localization characteristics.
Paxillin is predominantly restricted to all sites of integrin adhesion
to the ECM through its recruitment via the C-terminal LIM
domains [60], while Hic-5 can translocate from adhesions to stress
fibers upon the application of external tensile strain [61], [62].
Consistent with Hic-5 being responsive to mechanical stimuli, Hic-
5 exhibited striking redistribution to stress fibers in cells treated
with the Rac1 inhibitor (Figure 4H) as well as cells expressing
N17Rac1 and V14RhoA (data not shown). Importantly, Hic-5
stress fiber localization was found to be independent of its
interaction with vinculin, which did not colocalize or exhibit
FRET with Hic-5 in these structures (Figure 4H). Therefore, these
data show that Hic-5 responds to RhoA activation-mediated
intracellular tension through increased association with vinculin in
adhesions as well as its redistribution to stress fibers. These data
also indicate that despite extensive sequence conservation between
paxillin and Hic-5, their molecular interactions and spatiotempo-
ral localizations can be regulated by the RhoGTPases to promote
functional diversity.
Vinculin ‘‘activation’’ state dictates the spatial interaction
with paxillin and Hic-5
Vinculin is comprised of three distinct domains, an amino-
terminal globular head, a flexible proline-rich linker and the
paxillin/Hic-5 interacting carboxyl-terminal tail [63], [64]. Each
domain exhibits the capacity to interact with a variety of proteins
including talin [65], PIP2 [66] and F-actin [67] (Figure 5A).
Furthermore, a high affinity intramolecular association between
the head and tail domain of vinculin is responsible for maintaining
vinculin in a ‘closed’ inactive state [64], [65]. Using a conforma-
tionally sensitive intramolecular FRET probe, it has been shown
that vinculin activation is predominantly restricted to sites of
integrin-mediated adhesion. In contrast, inactive vinculin is
distributed throughout the membrane/cytosol but was also seen
at adhesion contacts [68]. Importantly, the role of vinculin
activation on its ability to bind paxillin and/or Hic-5 has not been
determined.
In order to test the effect of vinculin activation state on its
interactions with paxillin/Hic-5 we performed apFRET using the
‘active’ T12 and ‘inactive’ A50I vinculin mutants (Figure 5A). The
vinculinT12 mutant lacks the ability to exhibit the autoinhibitory
head-tail interaction [69], while the vinculinA50I mutant has
enhanced head-tail affinity and is incapable of interacting with
talin but both retain the PIP2-binding site [64], [69]. A
vinculin880 mutant previously shown not to interact with paxillin,
as it lacks the paxillin and Hic-5 interacting carboxyl-terminus
[63], [70], was also used as a negative/background control for
subsequent FRET experiments. Western blot analysis revealed
that all of the vinculin constructs were expressed to similar levels
relative to the endogenous protein (Figure 5B) and consistent with
previous studies [70], the vinculin880 and T12 mutants increased
average adhesion size, while expression of the A50I mutant
decreased adhesion area relative to the wild type protein (data not
shown). ApFRET analyses revealed that as described earlier
(Figure 2), the wild type vinculin interacted with paxillin
predominantly in adhesion contacts (Figure 5C; upper panels).
In contrast, the interaction between paxillin and the active
vinculinT12 mutant was entirely restricted to adhesion contacts
(Figure 5C and D). Although plausible, it is unlikely that the T12
mutations directly affect the paxillin/Hic-5 binding domain of
vinculin as they are located outside the defined paxillin interaction
site [63]. Furthermore, we observed no changes in Pearson’s
Correlation analysis between paxillin or Hic-5 and the vinculin
T12 mutant (data not shown) and unlike talin no difference in
paxillin FRAP dynamics were observed in vinculin null cells
expressing wild type vinculin or the T12 mutant [71]. No
significant FRET (above that of the vinculin880 control level) was
observed in adhesions between paxillin and the inactive vinculi-
nA50I (Figure 5D), although a significant increase in FRET
efficiency relative to adhesion contact-localized FRET, was
observed between paxillin and vinculinA50I at the plasma
membrane (Figure 5C and D; 41.5% increase 66.6, P,0.0005).
These analyses indicate that paxillin interacts predominantly with
active vinculin in adhesions and vinculin in its inactive conforma-
Figure 3. The interaction between paxillin and vinculin in adhesions is spatially regulated by the activity of the RhoGTPases. (A)
Western blot of vinculin-YFP and myc-tagged Rac1 and RhoA mutant expression in NIH 3T3 cells used for FRET analyses. (B) Representative donor
(vinculin-YFP) and FRET efficiency images indicating that in the presence of wild type (wt) or active (V12Rac1) Rac1, paxillin and vinculin are within
FRET proximity. In contrast, inhibition of Rac1 (N17Rac1) or activation of RhoA (V14RhoA) results in a loss of adhesion-localized FRET. FRET image
zooms highlight representative FRET pattern of cells as indicated. (C) Quantitation of average FRET efficiency of mRFP-paxillin and vinculin-YFP in all
adhesions of cells expressing activation mutants of Rac1 and RhoA. (D) Adhesion area calculations for cells expressing mRFP-paxillin and vinculin-YFP
with indicated Rac1 and RhoA mutants. Expression of the active V12Rac1 mutant promotes the formation of smaller adhesions, while the dominant
negative N17Rac1 or active V14RhoA constructs induce an increase in adhesion area. Error bars are standard error of the mean from cells used for
FRET calculations. (E) Quantitation of average FRET efficiency of mRFP-paxillin and vinculin-YFP in all adhesions of cells in the presence of vehicle
(dH20) or 50 mM Rac1 inhibitor (NSC23766). (F) Quantitation of average adhesion area in cells treated with vehicle or 50 mM Rac1 inhibitor. Error bars
are standard error of the mean and values calculated from all adhesions from a minimum of 10 cells from 3 individual experiments. *=p,0.05,
**=p,0.005 and ***=p,0.0005. (G) Representative images of NIH 3T3 cells displaying increased vinculin-YFP cytosol/membrane localization
indicating positive FRET in both adhesion contacts and areas outside integrin-mediated adhesions. Treatment with 50 mM Rac1 inhibitor decreased
FRET in adhesion contacts with cytosolic/membrane FRET still observed. White lines highlight vinculin-YFP-positive adhesion areas. (H) Western blots
indicating an increase in endogenous vinculin recruitment to the membrane-enriched fraction of cells treated with 50 mM Rac1 inhibitor. (I)
Representative Western blots indicating no effect of the Rac1 inhibitor on the ability of endogenous paxillin and vinculin to coimmunoprecipitate,
n=3 individual experiments.
doi:10.1371/journal.pone.0037990.g003
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37990Figure 4. Rac1 inhibition or RhoA activation promotes mRFP-Hic-5 and vinculin-YFP FRET in adhesions. (A) Western blots of donor and
myc-tagged Rac1 and RhoA mutant expression. (B) Representative images of mRFP-Hic-5 and vinculin-YFP FRET in adhesions of cells expressing
wtRac1, N17Rac1, V14RhoA or V12Rac1 constructs. FRET image zooms highlight representative FRET pattern of cells as indicated. (C) Quantitation of
the FRET efficiency between mRFP-Hic-5 and vinculin-YFP in all adhesions and (D) average adhesion area in the presence of Rac1/RhoA activation
mutants. Error bars represent standard error of the mean and are calculated from a minimum of 10 cells from 3 individual experiments. (E)
Quantitation of the FRET efficiency between mRFP-Hic-5 and vinculin-YFP and (F) average adhesion area in the presence of 50 mM Rac1 inhibitor.
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could play a role in maintaining vinculin in its inactive state at the
plasma membrane [68].
Interestingly, a significant increase in Hic-5 FRET efficiency
with the active vinculinT12 mutant was observed in adhesions
relative to the wild type protein (Figure 5E–G), while no
interaction was observed between Hic-5 and the inactive A50I
mutant of vinculin either in the adhesion contacts or at the plasma
membrane (Figure 5F and G). These data indicate that Hic-5 may
interact solely with the active form of vinculin in adhesion contacts
(Figure 5E–G) and that this appears to be dependent on the
activation of RhoA (Figure 4). Vinculin activation has been shown
to peak at the cell periphery during the Rac1-mediated process of
cell spreading [68]. However, RhoA activation has also been
shown to localize to the leading edge of cell protrusions [51] as
well as stimulate vinculin activation and talin binding [72].
Therefore, it is likely that a discrete balance of localized
RhoGTPase activity may dictate the levels of paxillin versus
Hic-5 binding to vinculin. Alternatively, tension-induced confor-
mational changes in vinculin [73], post-translational modifications
(e.g. phosphorylation) of any or all three of the proteins or the
absence/presence of auxiliary proteins/phospholipids necessary to
maintain complex formation may also influence which interaction
predominates. Indeed, it is likely that phosphorylation of paxillin
has a role in spatially regulating the interaction between vinculin
and paxillin as the latter has been shown to be highly
phosphorylated in peripheral focal complexes relative to more
mature adhesions [31] and this has been associated with
modulating the paxillin-FAK interaction [74]. However, in vitro
coimmunoprecipitation data suggests that vinculin is able to
interact with both phosphorylated and unphosphorylated paxillin
[38], [39].
The interaction between Hic-5 and vinculin
predominates in 3D matrix adhesions
Cells rarely encounter 2D substrata during migration in vivo,
therefore examination of cellular adhesions in 3D ECM model
systems is essential for a more complete understanding of the
physiologic regulation of cell adhesion and migration. Three
dimensional matrix adhesions are morphologically and biochem-
ically distinct from 2D adhesion contacts, with the former
containing less phosphorylated FAK [29]. Integrin-mediated
adhesions formed in 3D ECM are highly elongated, dynamic,
align with fibrous cell-derived ECM (Figure 6A) and contain
paxillin, Hic-5 and vinculin [25], [75]. Importantly, the comple-
ment of intracellular protein:protein interactions in 3D adhesions
remains entirely unexplored.
A key functional/signaling difference between 2D and 3D ECM
model systems is the distinct activation profiles of the RhoGT-
Pases. Relative to cell migration on 2D ECM, cells migrating in
3D matrices display reduced Rac1 activation, which promotes
uniaxial protrusions and persistent directional migration [75].
Consistent with reduced Rac1 activity in 3D microenvironments
we found that despite high colocalization (Figure 6B) the
interaction between paxillin and vinculin was attenuated in 3D
matrix adhesions (Figure 6C and D).
Importantly, in contrast to 2D (Figure 2F), the highest FRET
efficiency was between Hic-5 and vinculin in 3D matrix adhesions
(Figure 6C and E). Interestingly, a paxillin and vinculin interaction
was still observed at the plasma membrane (Figure 6D) consistent
with the effect of reduced Rac1 activity observed in cells in a 2D
setting (Figure 3). Importantly, no significant difference between
the colocalization of vinculin with paxillin or Hic-5 was observed
(Figure 6B). These data indicate that vinculin predominantly
interacts with Hic-5 in fibroblast 3D adhesion contacts and are
consistent with the reduced levels of Rac1 activity associated with
cells migrating in 3D matrices [75] as well as the essential role of
Hic-5 in 3D adhesion contact function as observed in breast
cancer cells [25].
Inhibition of Rac1 specifically increases paxillin immobile
fraction in adhesions
Adhesion contacts are dynamic structures that must assemble,
stabilize and disassemble to enable productive and efficient cell
locomotion [24], [25]. The individual proteins that reside in
adhesions are also highly dynamic, exhibiting constant exchange
with the surrounding plasma membrane and cytoplasm, with
proteins remaining in adhesions for seconds to minutes before
being replaced [76]. Indeed, the dynamics of individual proteins
within an adhesion, have been shown to be intimately linked with
adhesion assembly, maturation and disassembly to regulate cell
migration [77], [78]. Fluorescence recovery after photobleaching
(FRAP) is routinely used to assess the dynamics of individual
proteins within adhesions and provides information on the rate at
which fluorophore-tagged proteins exchange (half-life, t1/2), as
well as identifying the stably associated population of a particular
protein within an adhesion (immobile fraction). Having revealed a
role for the RhoGTPases in regulating paxillin and Hic-5
interaction with vinculin we used FRAP to examine whether
changes in RhoGTPase activity also affects the individual protein’s
dynamics within adhesions.
Interestingly, pharmacologic inhibition of Rac1 (Figure 7A and
B) or expression of the dominant negative N17Rac1 (Figure 7C)
resulted in a significant increase in paxillin’s immobile fraction
(Figure 7B–E) and thus its stability in adhesions. Importantly, this
was not dependent on the interaction between paxillin and
vinculin in adhesions as this binding is prevented under these
conditions (Figure 3). The significant increase in the immobile
fraction of paxillin that was observed upon Rac1 inhibition was
not seen with vinculin (Figure 7D and E), Hic-5, FAK or zyxin
(Figure S6). Furthermore, manipulation of Rac1 activity did not
have a significant effect on the t1/2 of either paxillin, Hic-5 or
vinculin (Figure 7D, E and Figure S6A, B). The absence of any
significant change in t1/2 values suggests that the mechanisms
controlling the dynamic, mobile fraction of paxillin are indepen-
dent of Rac1. Instead, Rac1 activation specifically regulates
paxillin retention/stabilization in adhesion contacts.
Rac1 inhibition increases actopaxin immobile fraction in
adhesions and promotes the paxillin-actopaxin
interaction
The most stable components of adhesion contacts are likely to
be those that perform structural rather than signaling roles.
Actopaxin (a-parvin) is a paxillin binding partner, which through
its interaction with F-actin may serve a predominantly structural
Error bars are standard error of the mean from a minimum of 13 cells from 4 individual experiments. *=p,0.05, **=p,0.005 and ***=p,0.0005. (G)
Western blots of vinculin-YFP and Hic-5 coimmunoprecipitation. A small but consistent increase in the interaction of vinculin-YFP with both
endogenous and fluorophore-tagged Hic-5 was seen upon Rac1 inhibition. Data is representative of n=4 individual experiments. (H) Images and line
profile of mRFP-Hic-5 localization to stress fibers upon Rac1 inhibition.
doi:10.1371/journal.pone.0037990.g004
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hypothesized that the interaction between paxillin and actopaxin
may be required for the observed Rac1-mediated retention of
paxillin in adhesions (Figure 7). Expression of the dominant
negative N17Rac1 or treatment with the Rac1 inhibitor resulted in
a significant increase in YFP-actopaxin immobile fraction
(Figure 8A–C). Furthermore, the interaction between paxillin
and actopaxin, as measured by apFRET, was also increased in
adhesions upon Rac1 inhibition (Figure 8D and E). Actopaxin has
been reported to exist predominantly in a stable complex with ILK
and PINCH [80] and this ternary complex has been shown to
promote RhoA-dependent adhesion maturation [81]. Interesting-
ly, YFP-ILK FRAP dynamics were unaffected by Rac1 inhibition
(Figure S7). Taken together these data suggest that actopaxin and
paxillin immobilization in adhesions is regulated by the activity of
the RhoGTPases and that their direct interaction may serve a
structural role in adhesions under RhoA-mediated tension.
Importantly, this also suggests a novel ILK-independent role for
actopaxin in RhoGTPase mediated adhesion stabilization.
Conclusions
The data presented herein enable us to propose a model
whereby Rac1 and RhoA activity spatially regulates the direct
interaction of vinculin with paxillin and Hic-5 during adhesion
maturation. High Rac1 activity as observed at the cell periphery
during migration [50], [51], promotes paxillin and active vinculin
interaction in newly established focal complexes (Figure 9-1),
which is reduced as adhesions mature (Figure 9-2) or lost
completely during the transition to high RhoA adhesions
(Figure 9-3) as observed in cells under mechanical tension. Indeed,
evidence from analysis of adhesion dynamics in paxillin and
vinculin knockout fibroblasts suggests that their interaction may be
necessary for nascent adhesion contact stabilization and matura-
tion as both cell types exhibit an increase in smaller highly unstable
peripheral adhesions [25], [28], [33]. In contrast, the interaction
of vinculin with Hic-5 is enhanced later in the adhesion
maturation process in conjunction with the activation of RhoA
(Figure 9-3) and may thus serve a mechanosensory or mechan-
otransduction role. Indeed, consistent with a role for Hic-5 in
adhesion contact stabilization, fibroblasts devoid of Hic-5 expres-
sion exhibit reduced collagen gel contractility due to the inability
of mature adhesions to persist and efficiently transmit mechanical
force [82].
Given the known roles of both paxillin and Hic-5 as hubs for
integrating RhoGTPase signaling [6], [25], it is also plausible that
a paxillin/Hic-5-driven feedback loop exists to regulate and fine-
tune appropriate spatiotemporal Rac1/RhoA signaling and in
turn adhesion dynamics and maturation. For example, paxillin can
both activate and inhibit Rac1 through indirect interactions with
the Rac1 GEF PIX [83] and the Rac1 GAP CdGAP [84]
respectively. Furthermore, paxillin and Hic-5 differentially regu-
late RhoGTPase activity in cells migrating through 3D microen-
vironments to modulate cell invasion mechanisms and metastasis
[25]. Importantly, despite the profound importance of the
RhoGTPases in adhesion contact formation and dynamics in 2D
and 3D microenvironments [17], [22], [25], [85], their cellular
activation has yet to be localized to sites of adhesion, but rather is
tightly restricted at the leading edge of cell protrusions [50], [51].
This may reflect limitations in the spatiotemporal resolution of
currently available probes and thus may suggest that adhesion-
localized changes in Rac1 and RhoA are small and/or highly
transient.
The process of cell migration requires the RhoGTPase-
dependent formation and maturation of integrin-mediated adhe-
sion contacts [3]. Our data provide the first description of the
molecular consequences of Rac1 and RhoA activation in 2D and
3D adhesions in a cellular environment. Furthermore, these
analyses begin to decipher the complexity of protein:protein
interactions necessary for adhesion maturation and force trans-
mission during cell migration. The list of proteins that localize to
sites of integrin-ECM attachment is ever expanding [4], yet the
complex interrelationship between these proteins is largely
undetermined. FRET and FRAP approaches in combination with
biochemical analyses, bioinformatics as well as super-resolution
imaging techniques, such as iPALM [86], will enable modeling of
adhesion ultrastructure and dynamics at a molecular level during
physiologic and pathophysiologic cell migration.
Materials and Methods
Antibodies and reagents
To specifically identify endogenous paxillin and Hic-5 by
Western blotting and immunofluorescence the mouse anti-paxillin
(clone 165) and mouse anti-Hic-5 (BD Biosciences, Franklin Lakes,
NJ) were utilized. For detection of both paxillin and Hic-5 by
immunofluorescence mouse anti-paxillin (clone 349) was used (BD
Biosciences). Analysis of endogenous and YFP-tagged vinculin and
vinculin mutants by immunofluorescence and Western blotting as
stated was performed using the mouse anti-vinculin (VIN-11-5)
(Sigma Aldrich, St Louis, MO) and rabbit anti-GFP (Santa Cruz
Biotechnology, Santa Cruz, CA). Other antibodies used for
immunofluorescence and Western blotting include mouse anti-c-
myc (clone 9E10; Developmental Studies Hybridoma Bank at the
University of Iowa, Iowa City, IA); goat anti-transaldolase (Santa
Cruz Biotechnology); mouse anti-b1 integrin (BD Biosciences);
mouse anti-alpha tubulin, rabbit anti-calnexin and rabbit anti-
fibronectin (Sigma Aldrich); rabbit anti-phospho-myosin light
chain 2 (Ser19) (Cell Signaling Technology, Inc., Danvers, MA),.
Rhodamine-conjugated phalloidin (Invitrogen, Carlsbad, CA) and
49,6-diamidino-2-phenylindole (DAPI) (Sigma Aldrich) were used
for fluorescent detection of F-actin and the cell nucleus respec-
tively. The Rac1 inhibitor, NSC23766, was used at a concentra-
tion of 50 mM and was purchased from EMD Chemicals (San
Diego, CA).
Cell culture
NIH 3T3 (ATCC, Manassas, VA) cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% (v/v) fetal calf serum (Invitrogen), L-glutamine, 1 mM
sodium pyruvate and 1% (v/v) penicillin and streptomycin.
Transient transfection of tagged proteins was performed using
Figure 5. Vinculin activation state spatially regulates its interaction with paxillin and Hic-5. (A) Schematic of vinculin highlighting the
distinct domains and associated binding partners as well as mutant constructs used for FRET experiments. (B) Western blot of vinculin-YFP (FRET
donor) mutant protein expression in mRFP-paxillin-expressing NIH 3T3 cells. (C) Representative images and (D) quantitation of vinculin-YFP activity
mutant’s FRET efficiency with mRFP-paxillin. Error bars are standard error of the mean from a minimum of 12 cells from 3 individual experiments.
Statistical analyses are relative to the vinculin880-YFP mutant, which lacks the paxillin interacting domain. (E) Western blot of vinculin-YFP (FRET
donor) mutant protein expression in mRFP-Hic-5-expressing NIH 3T3 cells. (F) Quantitation and (G) representative images of mRFP-Hic-5 FRET with
vinculin-YFP mutants. *=p,0.05 and ***=p,0.0005.
doi:10.1371/journal.pone.0037990.g005
RhoGTPases Regulate Protein: Protein Interactions
PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e37990Figure 6. Vinculin preferentially interacts with Hic-5 rather than paxillin in 3D adhesion contacts. (A) Images of NIH 3T3 cells spread on
2D fibronectin (FN) or 3D cell-derived matrix (CDM) for 4hrs stained for paxillin/Hic-5 (green), fibronectin (blue) and F-actin (red). (B) Average
Pearson’s Correlation analyses of mRFP-paxillin or mRFP-Hic-5 with vinculin-YFP in 3D adhesions reveals no significant difference in colocalization. (C)
Quantitation and representative images of (D) mRFP-paxillin and (E) mRFP-Hic-5 FRET efficiency with vinculin-YFP in 3D adhesions demonstrating
FRET between vinculin-YFP and mRFP-Hic-5 but not mRFP-paxillin in 3D adhesions. Error bars are standard error of the mean and are calculated from
a minimum of 15 cells from 3 individual experiments.
doi:10.1371/journal.pone.0037990.g006
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4mg cDNA unless otherwise stated.
Immunofluorescence
Immunofluorescence was performed as previously described
[25]. Briefly, 4610
4 NIH 3T3 cells were spread on 10 mg/ml FN
or 3D cell-derived matrices (CDM)-coated coverslips for indicated
times in complete media then washed once with PBS. Cells were
Figure 7. Rac1 inhibition specifically affects the dynamics of paxillin in adhesions. (A) Images of FRAP time series of GFP-paxillin-
expressing NIH 3T3 cells 650 mM Rac1 inhibitor. Inset are pseudo-colored images of the adhesions undergoing FRAP analysis highlighting a
reduction in the GFP-paxillin recovery. (B) Compiled fluorescence recovery curves for GFP-paxillin in adhesions from n=3 individual experiments 6
50mM Rac1 inhibitor and (C) with wtRac1 or N17Rac1. (D) Quantitation of the t1/2 of fluorescence recovery and immobile fraction for GFP-paxillin and
vinculin-YFP 650 mM Rac1inhibitor. (E) Quantitation of the t1/2 of fluorescence recovery and immobile fraction for GFP-paxillin and vinculin-YFP with
wtRac1 or N17Rac1. FRAP analyses reveal a significant increase in the immobile fraction of GFP-paxillin, but not vinculin-YFP in cells with decreased
Rac1 activity. Error bars are standard error of the mean. *=p,0.05.
doi:10.1371/journal.pone.0037990.g007
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paraformaldehyde containing 1% TritonH X-100 diluted in PBS.
Samples were then washed three times with PBS and paraformal-
dehyde quenched at room temperature with 0.1 M glycine in PBS
for 15 mins. Samples were then washed with PBS and incubated
with 3% (w/v) bovine serum albumin (BSA) diluted in PBS
overnight at 4uC prior to immunofluorescence staining. Fixed cells
were stained with primary antibodies as indicated in 3% (w/v)
BSA. PBS with 0.05%Tween-20 was used for subsequent washes.
Cells were imaged using the Leica SP5 scanning confocal with a
HCX PL APO 63x/1.40–0.60 OIL l BL objective (Leica,
Bannockburn, IL).
Acceptor photobleaching Fluorescence Resonance
Energy Transfer (apFRET)
NIH 3T3 cells were transfected using Lipofectamine LTX
following the manufacturers standard instructions with a cDNA
ratio of 2:1 donor to acceptor. Twenty-four hours post-transfec-
tion, 35-mm glass-bottomed, poly-L-lysine dishes (Mat-tek) were
coated with 10 mg/ml FN diluted in PBS containing calcium and
magnesium overnight at 4uC. To prevent non-specific cell binding,
the dishes were blocked with 10 mg/ml heat-denatured bovine
serum albumin (BSA) for 30 minutes. 4610
4 cells were added to
each well and allowed to attach and spread overnight 37uC, 5%
(v/v) CO2. Remaining cells were lysed in hot 1x reducing sample
buffer for protein expression Western blot analyses. Where stated,
cells were treated with vehicle (dH20) or 50 mM Rac1 inhibitor
4 hours prior to fixation. The spread cells were then fixed for
15 minutes at room temperature with 4% (w/v) paraformaldehyde
with 1% TritonH X-100 diluted in PBS to deplete the cytosolic
fraction. The dishes were then washed with PBS and the
paraformaldehyde quenched with 0.1 M glycine in PBS for
15 minutes. Fixed cells were imaged in the YFP and RFP channel
on a Leica AF6000 LX deconvolution microscope using a 100x/
1.40–0.70 HCX PL APO objective and Leica DFC350 FX
camera at 262 binning. FRET imaging and calculations were
performed as described previously [42]. Briefly, a YFP image
Figure 8. Paxillin is immobilized in adhesions upon Rac1 inhibition through an increased interaction with actopaxin. (A)
Representative images of YFP-actopaxin-expressing NIH 3T3 cells used for FRAP analyses. YFP-actopaxin exhibits robust adhesion localization but a
reduction in non-adhesion localization upon Rac1 inhibition. (B) Compiled FRAP recovery curves for YFP-actopaxin in the presence of wtRac1 or
N17Rac1. Error bars represent standard error of the mean and n=3 individual experiments. (C) Immobile fraction quantitation for YFP-actopaxin with
wtRac1, N17Rac1 and 650 mM Rac1inhibitor. Error bars are standard error of the mean from a minimum of n=3 individual experiments. (D) Images
and (E) quantitation of YFP-actopaxin and mRFP-paxillin FRET in adhesion contacts upon Rac1 inhibition. Error bars are standard error of the mean
and are from all adhesions from a minimum of 11 cells from 3 individual experiments. *=p,0.05.
doi:10.1371/journal.pone.0037990.g008
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(acceptor) in the RFP channel. Following background subtraction,
the percentage FRET efficiency was calculated on a pixel by pixel
basis, as 1006[1–(donor intensity before photobleaching/donor
intensity after photobleaching)], using ImageJ software (Rasband,
W.S., National Institutes of Health, Bethesda, MD, USA; http://
rsb.info.nih.gov/ij/). FRET images were smoothed and displayed
as a color intensity scale. If the donor (YFP) and acceptor (mRFP)
are within FRET proximity (,10 nm), then upon donor
excitation, energy is transferred to the acceptor causing donor
quenching and acceptor excitation. Thus, if FRET proximity is
achieved, an increase in donor emission will be observed upon
acceptor photobleaching. [40], [41], [42].
To control for pixel shift aberrations and edge artifacts due to
fluctuations in temperature and focus drift during mRFP
photobleaching, the YFP images taken before and after photo-
bleaching were merged and pixel alignment fidelity assessed and
corrected. Only images in which all pixels could be aligned as
determined by multiple line profile through adhesion contacts and
Pearson’s Correlation coefficient analyses were used for subse-
quent FRET calculations. To measure FRET within adhesion
contacts, a mask was created from a thresholded YFP image
before photobleaching and measurements restricted to adhesions
of defined area. Membrane FRET was calculated by averaging the
FRET efficiency in all non-adhesion contact areas. Pearson’s
correlation, line profile and adhesion area analyses were
performed using the Image J software. Pearson’s correlation
coefficients were calculated from YFP and mRFP channel before
photobleaching images after background subtraction using the
Image Correlator Plus plug-in. The Pearson’s correlation reflects
the linear relationship between the localized intensities of the two
fluorophore-tagged proteins.
Cell fractionation
NIH 3T3 cells were spread overnight in the presence of serum
on two heat-denatured BSA blocked, 10 mg/ml FN-coated 10 cm
dishes at 4610
5 cells/dish. Cells were then treated with either
vehicle or 50 mM Rac1 inhibitor 4 hours prior to cell fraction-
ation. Cells were then fractionated using the Qproteome H cell
compartment kit (Qiagen) following the manufacturer’s instruc-
tions. The lysates collected were then analyzed by Western
blotting for enrichment of cell compartment proteins, transaldo-
lase (cytosol), b1 integrin and calnexin (membrane) to confirm
fractionation fidelity.
Coimmunoprecipitation
Global intracellular association of endogenous and exogenous
fluorophore-tagged paxillin or Hic-5 with vinculin was assessed
using coimmunoprecipitation. 1610
5 NIH 3T3 cells (transfected
as stated using Lipofectamine LTX; see Experimental Procedures,
apFRET) were spread on heat-denatured BSA blocked 10 mg/ml
FN-coated 60 mm dishes overnight at 37uC and 5% CO2 in the
presence of serum. Cells were treated with vehicle or 50 mM Rac1
inhibitor 4 hours before being resuspended in lysis buffer (50 mM
Figure 9. Schematic representation highlighting paxillin and
Hic-5 molecular interactions during RhoGTPase-dependent
adhesion maturation. (1) At the leading edge of a migrating cell
high Rac1 activity stimulates nascent adhesion formation in which the
interaction of paxillin with vinculin in its active conformation is
stimulated to promote adhesion stabilization and maturation. (2) As
adhesion contacts mature the levels of Rac1 and RhoA likely balance
and an equilibrium is reached and a steady state maintained whereby
paxillin, and to a lesser extent Hic-5, is interacting with active vinculin in
adhesions. Furthermore, at steady state paxillin is also in a complex with
vinculin in its inactive state in the membrane. (3) Elevated levels of
RhoA activity as is observed in cells under tension induces the loss of
paxillin-vinculin interaction and a distinct switch to paxillin binding to
actopaxin, which likely stabilizes the complex in adhesions. An increase
in RhoA and concomitant decrease in Rac1 activity promotes the direct
interaction of Hic-5 with active vinculin in contractile adhesions and
stimulates the redistribution of Hic-5 to stress fibers to function
potentially in adhesion strengthening and/or mechanosensing.
doi:10.1371/journal.pone.0037990.g009
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EDTA, 0.75% (v/v) TritonH X-100, 2 mM NaVO3, 1 mM PMSF
and 10 mg/ml leupeptin). Lysates were incubated on ice for
10 minutes and spun at 18,000 g for 5 minutes. The supernatants
were then collected and incubated with either 5 mg mouse anti-
paxillin clone165 (BD) or rabbit anti-GFP (Santa Cruz) for 2 hours
rotating at 4uC followed by a 1 hour incubation with protein A/G
beads (Santa Cruz). Samples were spun at 3,800 g for 1 minute
and washed three times with lysis buffer and bound protein
assessed by Western blotting.
3D cell-derived matrix (CDM) generation
Cell-derived matrices were generated as previously described
[25] using primary human foreskin fibroblasts (ATCC).
Fluorescence Recovery After Photobleaching (FRAP)
A Leica TCS SP5 laser-scanning confocal microscope equipped
with a multi-line 100 mW Argon laser as well as a 1mW HeNe
543 nm lasers was used for all FRAP experiments. NIH 3T3 cells
were transfected with cDNAs as stated using Lipofectamine LTX.
Twenty-four hours post-transfection cells were plated on pre-
blocked FN-coated glass-bottomed dishes in the presence of serum
for 16 hours. Where stated, cells were treated with vehicle or
50 mM Rac1 inhibitor 4 hours prior to FRAP analyses. Cells
expressing the YFP- or GFP-tagged constructs were imaged using
a HCX PL APO 63x/1,30 Glyc Corr 37uC objective in an
environmentally controlled chamber at 37uC and 5% CO2 in
complete DMEM growth medium.
Initial fluorescence intensity was measured at low laser power
(12%) followed by photobleaching of individual adhesion contacts
.1 mm
2 away from the cell periphery. YFP-tagged proteins were
photobleached using the 496, 514 and 543 nm laser lines while
GFP-tagged proteins were photobleached using the 476, 488 and
496 nm laser lines at 100% laser power for 4 iterations.
Fluorescence recovery was then monitored at low laser power
for 80–120 secs with images acquired at 2 sec intervals (40 to 60
iterations). Images were background subtracted and corrected for
photobleaching as determined through monitoring fluorescence
intensity of a non-photobleached adhesion contact in the image
over the recovery period. FRAP analyses were performed using
Image J software. The percentage mobile (Mf) and immobile
fractions (If) were determined by comparing the fluorescence
intensity in the photobleached region after recovery to plateau (F‘)
with the intensity before (Fi) and initially after bleaching (F0) using
the equations Mf =1006(F‘–F 0)/(Fi –F 0) and If =100– Mf. The
t1/2 of recovery was determined from the kinetic plot of
fluorescence recovery and calculated using GraphPad Prism
software. A minimum of 10 adhesion contacts from 5 individual
cells, were photobleached and fluorescence recovery monitored
per tagged protein and condition (n=3). Therefore, recovery
curves represent data from a minimum of 30 individual adhesions
from 3 separate experiments. To avoid misinterpretations and bias
arising from proteins exhibiting varying dynamics depending on
their specific location within an individual adhesion contact as
previously reported [87], [88], entire adhesions were photo-
bleached and their fluorescence recovery monitored.
Statistical Analyses
Independent data sets were determined to exhibit a normal
distribution using the Shapiro-Wick and Kolmogorov-Smirnov
tests of normality and were subjected to an unpaired Student’s t
test. Statistical analyses were performed using Excel and
GraphPad Prism software.
Supporting Information
Figure S1 Fluorescently tagged paxillin and vinculin
used for FRET experiments are expressed at endoge-
nous levels and interact in all adhesion areas. (A) Western
blots of NIH 3T3 cell lysates of cells transfected with YFP-tagged
donor and mRFP-tagged acceptors indicating similar expression
levels to the endogenous proteins. (B) Merged overlay of the
vinculin-YFP raw images before (red) and after (green) mRFP-
paxillin photobleaching. Line profiles indicate pixel colocalization
(no pixel shift aberrations), as well as FRET which is seen as an
increase in the fluorescence intensity post mRFP-paxillin photo-
bleaching (green line).
(TIF)
Figure S2 Fluorescently tagged Hic-5 and vinculin are
expressed at endogenous levels and FRET in all
adhesion areas above control levels. (A) Western blots of
NIH 3T3 cell lysates of cells transfected with fluorophore-tagged
donor and acceptor as indicated showing similar expression levels
to the endogenous proteins. (B) Merged overlay of the vinculin-
YFP raw images before (red) and after (green) mRFP-Hic-5
photobleaching. Line profiles indicate pixel colocalization, as well
as FRET which is seen as an increase in the fluorescence intensity
post mRFP-Hic-5 photobleaching (green line). Raw and processed
FRET images of control (C) mRFP and vinculin-YFP and (D)
mRFP-paxillin and zyxin-YFP FRET pairs. Line profiles indicate
no increase in YFP fluorescence after acceptor photobleaching and
thus no significant FRET.
(TIF)
Figure S3 Expression of N17Rac1 and V14RhoA enhanc-
es myosin light chain 2 (MLC2) phosphorylation. (A)
Representative Western blot and (B) quantitation of MLC2
phosphorylation (p-MLC2; Ser19) indicative of elevated RhoA
signaling in cells expressing the dominant negative (N17) Rac1 and
dominant active (V14) RhoA. N=4 individual experiments and
*=P,0.05. (C) Representative Western blot and (D) quantitation
of MLC2 phosphorylation in cells 650 mM Rac1 inhibitor. N=3
and ***=p,0.0005.
(TIF)
Figure S4 Pearson’s Correlation analyses reveals that
the changes of FRET are not due to changes in
colocalization. Pearson’s Correlation analyses of cells used for
FRET quantitation expressing either mRFP-paxillin and vinculin-
YFP or mRFP-Hic-5 and vinculin-YFP with (A and C) Rac1
mutant constructs and (B and D) 650 mM Rac1 inhibitor. No
significant difference in colocalization was ever observed.
(TIF)
Figure S5 Inhibition of Rac1 or activation of RhoA
promotes increased FRET between paxillin and vincu-
lin in the cytosol/membrane relative to the adhesion
contacts. Quantitation of the relative FRET efficiency
between mRFP-paxillin and vinculin-YFP in all adhesion
contacts in the cell versus the surrounding cytosol/membrane
upon expression of (A) wtRac1 or N17Rac1 and (B) 650 mM
Rac1 inhibitor treatment. Data represents a minimum of n=3
individual experiments and 7 individual cells. * =P,0.05 and
**=P,0.005.
(TIF)
Figure S6 Inhibition of Rac1 has no effect on Hic-5,
FAK or zyxin FRAP dynamics. FRAP recovery curves and
immobile fraction data for adhesions of cells expressing (A) GFP-
Hic-5650 mM Rac1 inhibitor, (B) GFP-Hic-5 (C) YFP-FAK and
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PLoS ONE | www.plosone.org 16 May 2012 | Volume 7 | Issue 5 | e37990(D) zyxin-YFP with wild type or dominant negative N17Rac1.
Data are combined analyses from a minimum of 10 adhesions
from 5 cells and 3 individual experiments. No significant
differences in either t1/2 or immobile fraction were observed
upon manipulation of Rac1 activity.
(TIF)
Figure S7 Inhibition of Rac1 has no effect on ILK FRAP
dynamics. FRAP recovery curves and immobile fraction data for
adhesions of cells expressing YFP-ILK with wild type or dominant
negative N17Rac1. Data are combined analyses from a minimum
of 10 adhesions from 5 cells and 3 individual experiments. No
significant differences in either t1/2 or immobile fraction were
observed upon manipulation of Rac1 activity.
(TIF)
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